Hiroaki Umebayashi
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus.
Journal: Modern rheumatology
Published: July 11, 2025
Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.
Journal: Pediatric rheumatology online journal
Published: June 19, 2025
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin-Associated Periodic Syndrome.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 04, 2025
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Journal: Frontiers in immunology
Published: December 19, 2024
Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis - secondary publication.
Journal: Modern rheumatology
Published: October 21, 2024
Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review.
Journal: Modern rheumatology
Published: February 05, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 04, 2023
Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.
Journal: International journal of rheumatic diseases
Published: September 02, 2022
Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study.
Journal: Modern rheumatology
Published: May 11, 2022
Social independence evaluation index for Japanese patients with childhood-onset chronic diseases.
Journal: Frontiers in pediatrics
Published: April 19, 2022
Transitioning from paediatric to adult rheumatological healthcare: English summary of the Japanese Transition Support Guide.
Journal: Modern rheumatology
Published: June 29, 2021
Last Updated: 09/26/2026